Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN)
Phase 3, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss
In the register
The register attaches this trial to N1087 (oral minoxidil) (Eurofarma Laboratórios), currently at “Phase 3” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Phase 3
- Sponsor
- Eurofarma Laboratorios S.A.
- Participants (registry)
- 372
- Start
- January 2027 (planned)
- Primary completion
- July 2028 (planned)
- Study completion
- August 2028 (planned)
- Last registry update
- January 2026
- Countries
- —
Conditions studied: Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia
Interventions: N1087, Placebo
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.